A detailed history of Pnc Financial Services Group, Inc. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 245 shares of WVE stock, worth $3,302. This represents 0.0% of its overall portfolio holdings.

Number of Shares
245
Previous 245 -0.0%
Holding current value
$3,302
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$4.38 - $6.48 $127 - $187
-29 Reduced 10.58%
245 $1,000
Q1 2024

May 10, 2024

BUY
$3.54 - $6.84 $938 - $1,812
265 Added 2944.44%
274 $1,000
Q4 2023

Feb 09, 2024

BUY
$4.16 - $6.87 $37 - $61
9 New
9 $0
Q2 2022

Aug 12, 2022

SELL
$1.23 - $3.25 $120 - $318
-98 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$7.99 - $37.6 $783 - $3,684
98 New
98 $0

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.17B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.